Increasing evidence for omalizumab in the treatment of bullous pemphigoid

• Sarah Lonowski, MD, MBA,
• Suzanne Sachsman, MD,
• Nirali Patel, MS,
• Allison Truong, MD,
• Vanessa Holland, MD

Affiliations

Sarah Lonowski, MD, MBA

Department of Medicine, Division of Dermatology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California; Correspondence to: Sarah Lonowski, MD, MBA, Department of Medicine, Division of Dermatology, David Geffen School of Medicine, University of California Los Angeles, 3107 Santa Monica Blvd Apt F, Santa Monica, CA 90404.

Suzanne Sachsman, MD

Department of Medicine, Division of Dermatology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California

Nirali Patel, MS

David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California

Allison Truong, MD

Department of Medicine, Division of Dermatology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California

Vanessa Holland, MD

Department of Medicine, Division of Dermatology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California